SUMMARY OF PRODUCT CHARACTERISTICS

1. Name of the veterinary medicinal product

FleaCidal 50 mg spot-on solution for cats

2. Qualitative and quantitative COMPOSITION

Each 0.5 ml pipette contains

Active substance:

Fipronil 50.00 mg

Excipients

Butylhydroxyanisole (E 320) 0.10 mg

Butylhydroxytoluene (E 321) 0.05 mg

For the full list of excipients, see section 6.1

3. pharmaceutical form

Spot-on solution

Clear, colourless to yellowish solution

4. clinical particulars

4.1 Target species

Cat

4.2 Indications for use, specifying the target species

For the treatment of cats against flea infestations (Ctenocephalides spp.).

Insecticidal efficacy against new infestation with fleas persists for up to 4 weeks.

Although the product has not demonstrated an immediate acaricidal effect, acaricidal efficacy for up to 1 week against the tick Ixodes ricinushas been shown. If ticks of Ixodes ricinusare present when the product is applied, all the ticks may not be killed within the first 48 hours, but they may be killed within a week.

4.3 Contraindication

Do not use on sick (systemic disease, fever, etc.) or convalescent animals.

Do not use on rabbits, as adverse drug reactions and even death could occur.

Do not use on animals with hypersensitivity to the active substance or any of the other excipients.

4.4 Special warnings for each target species

The veterinary medicinal product does not prevent an infestation of the animal by ticks.

For the optimal control of flea problems in households with several animals all dogs and cats should be treated with an authorised insecticide.

Fleas from pets often infest animal's baskets, bedding and regular resting areas such as carpets and soft furnishings which should be treated, in case of massive infestation and at the beginning of the control measures, with a suitable insecticide and vacuumed regularly.

The influence of bathing/shampooing on the efficacy of this veterinary medicinal product in cats has not been investigated. However, from studies conducted in dogs, shampooing with a medicated shampoo, followed by thorough drying, 1 to 2 hours before treatment application and bathing once weekly over a period of 6 weeks has been shown not to affect the efficacy of this veterinary medicinal product against fleas in dogs. Bathing and intensive wetting of the coat should be avoided for the first 2 days following administration of the product.

4.5 Special precautions for use

i) Special precautions for use in animals:

In the absence of available data, the veterinary medicinal product should not be used on kittens less than 8 weeks old and/or weighing less than 1 kg.

It is important to make sure that the product is applied to an area where the animal cannot lick it off.

Do not allow recently treated animals to lick each other.

Avoid contact with the animal's eyes. Should the veterinary medicinal product come into contact with the eyes, rinse thoroughly at once with water.

Do not apply the veterinary medicinal product to wounds or skin lesions.

There may be an attachment of some ticks. For this reason transmission of infectious diseases cannot be excluded if conditions are unfavourable.

Specific studies investigating the safety of the product following repeated administration or at overdosage have not been conducted due to the known safety profile of the active substance and excipients.

ii) Special precautions to be taken by the person administering the veterinary medicinal product:

This veterinary medicinal product can cause mucous membrane and eye irritation. Therefore avoid contact of the product with mouth and eyes.

Should the veterinary medicinal product come into contact with the eyes, rinse thoroughly at once with water. If the eye irritation persists, seek medical help at once and show the package insert or label to the doctor.

Avoid contact with the skin. Should the product come into contact with the skin, wash immediately with soap and water. Wash hands after use.

Do not eat, drink or smoke during application.

People with known hypersensitivity (allergy) to fipronil or one of the other ingredients of the product (see 6.1) should avoid contact with the veterinary medicinal product.

Treated animals should not be handled until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry.

It is therefore recommended that animals are not treated during the day but during the early evening and that recently treated animals should not be allowed to sleep with owners, especially children.

Keep stored pipettes in original packaging until ready for use. In order to prevent children getting access to used pipettes, dispose of used pipettes immediately.

iii) Other precautions

The product may have adverse effects on painted, vanished or other household surfaces or furnishing.

4.6 Adverse reactions (frequency and seriousness)

If licking occurs, a brief period of hypersalivation may be observed due mainly to the nature of the carrier substance.

Among the extremely rare suspected adverse reactions, transient cutaneous reactions at the application site (scaling, local alopecia, pruritus, erythema) and general pruritus or alopecia have been reported after use.

Exceptionally, hypersalivation, reversible neurological signs (hyperaesthesia, depression, nervous signs) or vomiting have been observed after use.

4.7 Use during pregnancy, lactation or lay

Laboratory studies using fipronil have not shown any teratogenic or embryotoxic effect. No studies have been carried out on pregnant or lactating cats using this veterinary medicinal product. Therefore its use during pregnancy and lactation should only be after a relevant benefit-risk analysis made by the treating veterinarian.

4.8 Interactions with other medicinal products and other forms of interactions

None known

4.9 Amounts to be administered and administration route

Method of application and posology:

Only by topical application to the skin.

1 pipette of 0.5 ml is sufficient for the treatment of a cat corresponding to a recommended minimum dose of 5 mg fipronil/kg body weight.

The minimum interval between two treatments should be not less than 4 weeks.

Advice for the safe application:

Disconnect one of the blisters from the blister card. This helps to avoid accidental opening of the adjacent blister package in order to protect the still unopened pipettes from exposure to humidity. Open the blister with scissors. To avoid damaging of the pipette cut along the line marked with the scissors icon. Carefully peel back the foil from the cut off end and withdraw the pipette.

Hold the pipette upright. Tap lightly to ensure the entire liquid contents are within the main body of the pipette. Bend the upper border strip backwards. Then the pipette can be set aside, if necessary. To open the pipette snap off the top of the pipette along the scored line.

Part the coat between the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze the pipette several times to empty its content completely and directly onto the skin in one spot.

Application of the solution near the base of the head minimises the possibility that the animal will lick the solution off. Care should be taken after the application that animals do not mutually lick off the solution.

Care should be taken to avoid excessive wetting of the hair with the product since this will cause a sticky appearance of hairs at the treatment spot.

However should this occur, it will disappear within 24 hours post application.

4.10 Overdose (symptoms, emergency procedure, antidotes), if necessary

The toxicity of the veterinary medicinal product administered to the skin is very low. The risk of experiencing adverse effects (see section 4.6) may however increase when overdosing, so animals should always be treated with the correct pipette size according to body weight.

4.11 Withdrawal period

Not applicable

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic Group: Ectoparasiticides; Fipronil

ATCvet Code: QP53AX15

Fipronil is an insecticide belonging to the group of phenylpyrazole. It acts by inhibiting the GABA complex, binding to the chloride channel thereby blocking pre- and post-synaptic transfer of chloride ions across the membrane. This results in uncontrolled activity of the central nervous system and hence to death in insects.

Fipronil acts as an insecticide against fleas (Ctenocephalidesspp.) and as an acaricide against ticks (Ixodes ricinus).

Fleas are killed within 24 hours.

5.2 Pharmacokinetic particulars

The veterinary medicinal product distributes itself within 24 – 48 hours over the entire skin of the animal.

The absorption of fipronil is negligible in cats following topical application.

The concentration of fipronil on the fur decreases over time.

6. PHARMACEUTICAL PARTICULARS

Butylhydroxyanisole (E 320)

Butylhydroxytoluene (E 321)

Diethylene glycol monoethyl ether

6.2 Incompatibilities:

None known

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 30 months

6.4 Special precautions for storage

This veterinary medicinal product does not require any special storage conditions.

Store in the original package.

6.5 Nature and composition of immediate packaging

Pipettes containing an extractable volume of 0.5 ml.

The pipettes are made of:

- bottom foil: polyethylene terephthalate/polypropylene

- lidding foil: polyethylene terephthalate/aluminium

To protect the content of the pipettes from moisture and light the pipettes are individually packed in blister foils made of:

- cold-form foil for blister: polyvinyl chloride/(biaxially) oriented poly­amide/aluminium/polyvinyl chloride

- lidding foil for blister: polyethylene terephthalate/aluminium

Cartons containing 1, 2, 3 or 6 pipettes

Not all pack sizes may be marketed.

6.6 Special precaution for the disposal of unused veterinary medicinal product or waste materials derived from the use of such product

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. Fipronil may be harmful to aquatic organisms. Do not contaminate ponds, waterways or ditches with the product or empty container.

7. MARKETING AUTHORISATION HOLDER

Perrigo Pharma International D.A.C.

Treasury Building

Grand Canal Street Lower

Dublin 2

Ireland

8. MARKETING AUTHORISATION NUMBER

Vm 16804/4003

9. DATE OF FIRST AUTHORISATION

10 August 2015

10. DATE OF REVISION OF THE TEXT

June 2016

Approved: 22 June 2016